AbbVie Income from Continuous Operations 2010-2024 | ABBV

AbbVie income from continuous operations for the twelve months ending September 30, 2024 was $5.133B, a 21.29% decline year-over-year.

  • AbbVie annual income from continuous operations for 2023 was $4.873B, a 58.86% decline from 2022.
  • AbbVie annual income from continuous operations for 2022 was $11.845B, a 2.56% increase from 2021.
  • AbbVie annual income from continuous operations for 2021 was $11.549B, a 149.87% increase from 2020.

AbbVie Income from Continuous Operations 2010-2024 | ABBV

  • AbbVie annual income from continuous operations for 2023 was $4.873B, a 58.86% decline from 2022.
  • AbbVie annual income from continuous operations for 2022 was $11.845B, a 2.56% increase from 2021.
  • AbbVie annual income from continuous operations for 2021 was $11.549B, a 149.87% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Novo Nordisk (NVO)$460.6B
Johnson & Johnson (JNJ)$368.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
AstraZeneca (AZN)$197.8B
Pfizer (PFE)$142.2B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B